MedTrace Logo

China Registry of Non-disabling Ischemic Cerebrovascular Events

NCT03079674 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2017-05-11

No results posted yet for this study

Summary

The burden of non-disabling ischemic cerebrovascular events (NICE) is significantly increased. In order to achieve accurate risk stratification and effective treatments, developing new diagnostic, therapeutic, and prognostic strategies is indispensable. Chinese registry of NICE is a national multi-center prospective study aimed to explore the epidemiology, new biomarkers, risk factors and prognostic models.

Conditions

  • Transient Ischemic Attack
  • Minor Stroke

Interventions

OTHER

observational only- no intervention

observational only- no intervention

Sponsors & Collaborators

  • National Health and Family Planning Commission, P.R.China

    collaborator OTHER_GOV

  • Beijing Tiantan Hospital

    collaborator OTHER

  • The First Affiliated Hospital of Zhengzhou University

    lead OTHER

Principal Investigators

  • Yuming Xu, MD, PhD · The First Affiliated Hospital of Zhengzhou University

  • Yilong Wang, MD, PhD · Beijing Tiantan Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2019-02-01
Completion
2020-02-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03079674 on ClinicalTrials.gov